NOMAD Power Solutions, Inc. (NMAD) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$3.54

From 52W high−55.22%

Volume104461.00

Market cap$57.96M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$3.54

From 52W high

−55.22%

Volume

104461.00

Market cap

$57.96M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.3x

P/E (TTM)

—

RSI (14)

43.3

MomentumView details →

1D Return

+2.27%

YTD Return

−9.67%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−5.3x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

2.4x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−36.32%

ROA (TTM)

−32.59%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+20.75%

EBITDA YoY

—

MomentumView details →

1D Return

+2.27%

YTD Return

−9.67%

1Y Return

−12.99%

RSI (14)

43.3

vs 50D SMA

−7.57%

vs 200D SMA

−16.75%

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

12.87x

Quick Ratio

12.87x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.16

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−8.69M

Op. CF (TTM)

−5.46M

Latest newsMore news →

No recent news for NMAD.

Similar companies

Clene Inc.CLNN Xilio Therapeutics, Inc.XLO RenovoRx, Inc.RNXT Heron Therapeutics, Inc.HRTX Verrica Pharmaceuticals Inc.VRCA XBiotech Inc.XBIT Find similar companies →

Latest newsMore news →

No recent news for NMAD.